Surgery after coronary stenting: the role of antiplatelet therapy on ischemic and hemorrhagic complications

被引：0
|
作者：
Rossini, R. [1 ]
Musumeci, G. [1 ]
Capodanno, D. [2 ]
Calabria, P. [3 ]
Limbruno, U. [3 ]
Lettieri, C. [4 ]
Iaccarino, D. [4 ]
Russo, N. [1 ]
Inashvili, A. [1 ]
Gavazzi, A. [1 ]
机构：
[1] Hosp Riuniti Bergamo, Bergamo, Italy
[2] Ferrarotto Hosp, Inst Cardiol, Dept Cardiovasc, Catania, Italy
[3] Mater Misericordiae Univ Hosp, Dept Cardiol, Grosseto, Italy
[4] Osped Carlo Poma, Mantua, Italy
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：321 / 321
页数：1
相关论文
共 50 条
  • [21] Noncardiac surgery after coronary stenting; early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events
    Schouten, Olaf
    van Domburg, Ron T.
    Bax, Jeroen J.
    de Jaegere, Peter J.
    Dunkelgrun, Martin
    Feringa, Harm H.
    Hoeks, Sanne
    Vidakovic, Radosav
    Poldermans, Don
    CIRCULATION, 2006, 114 (18) : 731 - 731
  • [22] Noncardiac surgery after coronary stenting: Early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events
    Schouten, Olaf
    van Domburg, Ron T.
    Bax, Jeroen J.
    de Jaegere, Peter J.
    Dunkelgrun, Martin
    Feringa, Harin H. H.
    Hocks, Sanne E.
    Poldermans, Don
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (01) : 122 - 124
  • [23] Antiplatelet effect of ticlopidine after coronary stenting
    Neumann, FJ
    Gawaz, M
    Dickfeld, T
    Wehinger, A
    Walter, H
    Blasini, R
    Schomig, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (07) : 1515 - 1519
  • [24] Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting
    Brener, Sorin J.
    Serruys, Patrick W.
    Morice, Marie-Claude
    Mehran, Roxana
    Kappetein, Arie Pieter
    Sabik, Joseph F., III
    Liu, Yangbo
    Dressler, Ovidiu
    Ben-Yehuda, Ori
    Stone, Gregg W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (17) : 2086 - 2087
  • [25] REPLY: The Optimal Duration of Dual- Antiplatelet Therapy After Coronary Stenting
    Palmerini, Tullio
    Biondi-Zoccai, Giuseppe
    Stone, Gregg W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (17) : 2210 - 2211
  • [26] Efficacy and safety of antiplatelet therapy including ticlopidine after coronary artery stenting
    Namiki, A
    Ishikawa, M
    Nakamura, M
    Yamaguchi, T
    ADVANCES IN CORONARY ARTERY DISEASE, 2001, : 611 - 614
  • [27] Antiplatelet therapy after coronary stenting and its importance in total joint arthroplasty
    Harrasser, N.
    Harnoss, T.
    Brettner, F.
    Liska, F.
    Pauschinger, M.
    ORTHOPADE, 2012, 41 (06): : 477 - 481
  • [28] Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting
    Karjalainen, Pasi P.
    Porela, Pekka
    Ylitalo, Antti
    Vikman, Saila
    Nyman, Kai
    Vaittinen, Mari-Anne
    Airaksinen, Tuukka J.
    Niemela, Matti
    Vahlberg, Tero
    Airaksinen, K. E. Juhani
    EUROPEAN HEART JOURNAL, 2007, 28 (06) : 726 - 732
  • [29] Randomized comparison of cilostazol vs ticlopidine for antiplatelet therapy after coronary stenting
    Takeyasu, N
    Watanabe, S
    Noguchi, Y
    Ishikawa, K
    Fumikura, Y
    Yamaguchi, L
    CIRCULATION JOURNAL, 2005, 69 (07) : 780 - 785
  • [30] Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting
    Karjalainen, Pasi
    Ylitalo, Antti
    Porela, Pekka
    Airaksinen, Tuukka
    Vikman, Saila
    Niemela, Matti
    Nyman, Kai
    Vaittinen, Marianne
    Airaksinen, Juhani
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 199M - 199M
12345